Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID -19 Rapid Antigen Test.
An independent evaluation by the National Institutes of Health (NIH) RADx Variant Task Force has determined that the INDICAID test detects the […]
GARDEN GROVE, CA, April 25, 2022 — PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that its EUA approved INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) is now available for […]
April 04, 2022
Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen test. A sub-variant of Omicron designated BA.2 (B.1.1529.2) was detected in the U.S. in January 2022, and the Centers […]
Despite its pervasiveness and spikes in Asia and Europe, the Covid-19 Omicron BA.2—dubbed the Stealth Omicron by the World Health Organization (WHO)—has appeared to have lost its choke-hold on the U.S. “It’s stealthy no more,“ Carl Zimmer remarks in his New York Times piece.
Omicron BA.2 […]
March 16, 2022 : The biotech conglomerate, PHASE Scientific USA, announced the FDA’s EUA green-light to launch INDICAID® Covid-19 Rapid Antigen Over-the-Counter (OTC)
tests nationwide. With INDICAID® OTC Delivered to leading retailers across the […]
GARDEN GROVE, Calif., March 22, 2022 /PRNewswire/ — PHASE Scientific International, LTD (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that its INDICAID® COVID-19 Rapid Antigen […]
Late last year, the American Medical Association (AMA) released an updated version of its document, ‘Special coding advice during COVID-19 public health emergency.’
This updated version, labeled v3.2, provides a broader list of coding scenarios, now 26 from the […]
As PHASE Scientific USA continues to monitor the pandemic on a global scale, the spotlight has fallen on Hong Kong, where the count of daily COVID-19 cases has reached upwards of 4,000 for the very first time.
The steep surge of cases has inundated […]
The B.1.1.529 variant, termed the Omicron variant, is a highly transmissible SARS-CoV-2 variant of concern. It is important that current SARS-CoV-2 diagnostic tests remain capable of detecting the B.1.1.529 variant. This white paper describes our evaluation of the INDICAID® COVID-19 Rapid Antigen Test when used to detect specimens containing the […]
February 4, 2022 : Set out below are Frequently Asked Questions (FAQs) regarding implementation of the Families First Coronavirus Response Act (FFCRA) and the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). These FAQs have been prepared jointly by the […]
